產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
- 400-999-210024小時服務(wù)熱線
產(chǎn)品概述
名稱 | MFC (小鼠胃癌細(xì)胞) (STR鑒定正確) |
別稱 | Mouse Forestomach Carcinoma |
種屬 | 小鼠 |
生長特性 | 貼壁細(xì)胞 |
細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
凍存條件 | 凍存液:55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮 |
培養(yǎng)方案A(默認(rèn)) |
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:2-1:4 |
推薦換液頻率 | 2-3次/周 |
背景描述 | MFC細(xì)胞是由錢書森、高進(jìn)等于1985年建立;利用源自615小鼠前胃鱗癌移植瘤FC瘤組織,小塊法培養(yǎng)得到,已傳132代;MFC細(xì)胞細(xì)胞在615小鼠皮下移植100%成功。 |
年齡(性別) | 不詳 |
組織來源 | 胃癌 |
細(xì)胞類型 | 腫瘤細(xì)胞 |
腫瘤類型 | 胃癌細(xì)胞 |
STR鑒定
-
STR位點信息
18-3 17,18 6-7 15 5-5 12 X-1 27 1-2 15,16,17 7-1 30 8-1 16 1-1 10,15 19-2 12 15-3 21.3 12-1 16,17 6-4 15.3 4-2 20.3 3-2 13,14 2-1 16 13-1 17.1
11-2 13,14,18 17-2 15 -
STR鑒定圖
參考文獻(xiàn)
-
Oxyhaemoglobin saturation NIR-IIb imaging for assessing cancer metabolism and predicting the response to immunotherapy(2023/09/11)
作者:Zhiguo Fang, Chenlei Wang, Jingrun Yang
期刊:Nature Nanotechnology
DOI:10.1038/s41565-023-01501-4
影響因子 :38.300
引用產(chǎn)品:CL-0156
-
m6A Reader YTHDF1-targeting Engineered Small Extracellular Vesicles for Gastric Cancer Therapy Via Epigenetic and Immune Regulation(2022/12/09)
作者:Qing You, Fang Wang, Rong Du
期刊:ADVANCED MATERIALS
影響因子 :29.400
引用產(chǎn)品:CL-0156
-
Transfer of LncRNA CRNDE in TAM-derived exosomes is linked with cisplatin resistance in gastric cancer(2021/12/06)
作者:Lin Xin, Liqiang Zhou, Chuan Liu
期刊:Embo Reports
影響因子 :9.071
引用產(chǎn)品:CL-0156
-
GC-Derived EVs Enriched with MicroRNA-675-3p Contribute to the MAPK/PD-L1-Mediated Tumor Immune Escape by Targeting CXXC4(2020/08/21)
作者:Ping Li, Xingdong Luo, Yue Xie
期刊:Molecular Therapy-Nucleic Acids
DOI:10.1016/j.omtn.2020.08.020
影響因子 :8.800
引用產(chǎn)品:CL-0156
-
Compound Kushen Injection inhibits epithelial-mesenchymal transition of gastric carcinoma by regulating VCAM1 induced by the TNF signaling pathway(2023/07/17)
作者:Zhihong Huang, Chao Wu, Wei Zhou
期刊:PHYTOMEDICINE
DOI:10.1016/j.phymed.2023.154984
影響因子 :7.900
-
Potential crosstalk between SPP1?+?TAMs and CD8?+?exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer(2024/02/16)
作者:Yan Du, Yilin Lin, Lin Gan
期刊:Journal of Translational Medicine
DOI:10.1186/s12967-023-04688-1
影響因子 :7.400
引用產(chǎn)品:CL-0156
-
CHSY3 promotes proliferation and migration in gastric cancer and is associated with immune infiltration(2023/07/17)
作者:Xinkun Huang, Yonghui Liu, Chenyu Qian
期刊:Journal of Translational Medicine
DOI:10.1186/s12967-023-04333-x
影響因子 :7.400
引用產(chǎn)品:CL-0156
-
Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages(2021/08/18)
作者:Yan Yang, Yang Yang, Meili Chen
期刊:Biomaterials Science
影響因子 :6.600
-
New genetic insights into immunotherapy outcomes in gastric cancer via single-cell RNA sequencing and random forest model(2024/05/02)
作者:Dajun Yu, Jie Yang, BinBin Wang
期刊:CANCER IMMUNOLOGY IMMUNOTHERAPY
DOI:10.1007/s00262-024-03684-8
影響因子 :5.800
引用產(chǎn)品:CL-0156
-
RORα inhibits gastric cancer proliferation through attenuating G6PD and PFKFB3 induced glycolytic activity(2024/01/06)
作者:Xiaoshan Wang, Junyi Zhang, Yuwei Wu
期刊:Cancer Cell International
DOI:10.1186/s12935-023-03201-4
影響因子 :5.800
引用產(chǎn)品:CL-0156
-
Efficacy of anti-PD-1 monoclonal antibody combined with bevacizumab and/or Pseudomonas aeruginosa injection in transplanted tumor of MFC gastric cancer in mice and its mechanism in regulating tumor immune microenvironment(2023/07/01)
作者:Xiangyong Liu, Chao Yan, Aijie Yang
期刊:CLINICAL AND EXPERIMENTAL IMMUNOLOGY
影響因子 :4.600
引用產(chǎn)品:CL-0156
-
Closed-loop of Catalyzed Lactate Oxidization Synergistically Sensitizes Apoptosis and Ferroptosis for Cancer Therapy(2024/02/01)
作者:Yajun Ma, Jianquan Chen, Yan Yang
期刊:ChemNanoMat
影響因子 :3.800
引用產(chǎn)品:CL-0156
-
Akkermansia muciniphila improves gastric cancer treatment by modulating the immune microenvironment(2024/04/17)
作者:Jianming Fang, Huizhong Zhang, Xiaodong Zhang
期刊:Future Microbiology
影響因子 :3.100
引用產(chǎn)品:CL-0156
FAQs
Q:{{item.question}}
A:
產(chǎn)品資料
識別碼示意圖